Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19386177 | DEVICES, SYSTEMS, AND METHODS FOR MANAGING BLOOD FLOW | November 2025 | March 2026 | Allow | 4 | 0 | 0 | No | No |
| 19263935 | Catheter | July 2025 | October 2025 | Allow | 3 | 0 | 0 | No | No |
| 19256472 | URINE COLLECTION SYSTEMS, AND METHODS OF MAKING AND USING THE SAME | July 2025 | October 2025 | Allow | 3 | 1 | 0 | No | No |
| 19210550 | Wearable Urinary Collection Apparatus | May 2025 | July 2025 | Allow | 2 | 0 | 0 | No | No |
| 19173518 | DEVICES, SYSTEMS, AND METHODS FOR REVASCULARIZATION OF THE MYOCARDIUM | April 2025 | September 2025 | Allow | 5 | 1 | 0 | Yes | No |
| 19098279 | DEVICES, SYSTEMS, AND METHODS FOR MANAGING BLOOD FLOW | April 2025 | August 2025 | Allow | 4 | 0 | 0 | No | No |
| 19066822 | BLOOD TRANSFUSION FOR THROMBECTOMY DEVICES, AND SYSTEMS AND METHODS THEREOF | February 2025 | August 2025 | Allow | 6 | 1 | 1 | No | No |
| 19042647 | Wearable Urinary Collection Apparatus | January 2025 | April 2025 | Allow | 3 | 0 | 0 | No | No |
| 19009028 | Cerebrospinal Fluid Shunt With Flow Regulation | January 2025 | November 2025 | Allow | 11 | 1 | 0 | No | No |
| 18927053 | NEGATIVE PRESSURE BANDAGE | October 2024 | January 2025 | Allow | 3 | 0 | 0 | No | No |
| 18917388 | HYBRID DEVICES WITH DIMENSIONS THAT CAN BE ADJUSTED IN VIVO AND METHODS OF MANUFACTURING THEREOF | October 2024 | January 2025 | Allow | 3 | 0 | 0 | No | No |
| 18887672 | BAFFLE DEVICES AND RELATED METHODS FOR DELIVERY OF THERAPEUTIC COMPOSITIONS TO THE EYE | September 2024 | January 2025 | Allow | 4 | 1 | 0 | No | No |
| 18705844 | ATRIAL SHUNT DEVICE, MANUFACTURING METHOD, AND ATRIAL SHUNT SYSTEM USING SHUNT DEVICE | April 2024 | January 2025 | Allow | 9 | 1 | 0 | Yes | No |
| 18705324 | OSTOMY POUCH CLOSURE SYSTEM | April 2024 | November 2024 | Allow | 7 | 2 | 0 | No | No |
| 18636797 | EXTRACORPOREAL BLOOD TREATMENT APPARATUS AND METHOD FOR MONITORING PRESSURES IN AN EXTRACORPOREAL BLOOD TREATMENT APPARATUS | April 2024 | October 2025 | Allow | 18 | 1 | 0 | No | No |
| 18405565 | BODY FLUID MOVEMENT SYSTEM WITH ONE OR MORE SENSORS COUPLED TO A PATIENT REMOTE MONITORING SYSTEM | January 2024 | December 2024 | Allow | 12 | 2 | 0 | Yes | No |
| 18558428 | SYRINGE WITH LUER-LOCK CONNECTOR PROVIDED WITH A TAMPER-PROOF CAP | November 2023 | February 2026 | Allow | 28 | 0 | 0 | No | No |
| 18555476 | INSERTION TOOL FOR AN EYE DISEASE TREATMENT DEVICE | October 2023 | January 2026 | Allow | 27 | 0 | 0 | No | No |
| 18263460 | CUP FOR AUTOMATIC EXCRETION TREATING APPARATUS AND AUTOMATIC EXCRETION TREATING APPARATUS | July 2023 | November 2025 | Allow | 28 | 1 | 0 | No | No |
| 18265130 | UNDERPANTS-TYPE DISPOSABLE WEARING ARTICLE | June 2023 | September 2025 | Allow | 27 | 0 | 0 | No | No |
| 18254133 | IMPLANTABLE OCULAR DRAINAGE DEVICE FOR CONTROLLING INTRAOCULAR PRESSURE | May 2023 | February 2026 | Allow | 33 | 1 | 0 | No | No |
| 18198303 | ABSORBENT ARTICLE | May 2023 | December 2025 | Allow | 31 | 1 | 0 | Yes | No |
| 18303867 | ABSORBENT ARTICLES | April 2023 | March 2026 | Abandon | 35 | 1 | 0 | No | No |
| 18028786 | MEDICAL APPLIANCE | March 2023 | September 2025 | Allow | 30 | 0 | 0 | No | No |
| 18105668 | SYSTEMS AND METHODS FOR THE CONDITIONING OF CEREBROSPINAL FLUID | February 2023 | November 2025 | Allow | 33 | 0 | 0 | No | No |
| 17993590 | Flexible Medical Device Holders and Methods for Use | November 2022 | January 2026 | Abandon | 38 | 1 | 0 | No | No |
| 17981573 | Morning Erections Urine Collection Device | November 2022 | November 2025 | Abandon | 37 | 1 | 0 | No | No |
| 17920427 | SYSTEM OF A PULL-ON WEARABLE ARTICLE AND AN ABSORBENT ARTICLE | October 2022 | December 2025 | Allow | 37 | 2 | 0 | No | No |
| 18048093 | SELF-ADHESIVE SANITARY PRODUCT AND PREPARATION METHOD THEREOF | October 2022 | April 2025 | Allow | 29 | 0 | 0 | No | No |
| 17919226 | POWER MANAGEMENT FOR INTERATRIAL SHUNTS AND ASSOCIATED SYSTEMS AND METHODS | October 2022 | June 2025 | Allow | 32 | 0 | 0 | No | No |
| 17996064 | FEMALE EXTERNAL CATHETER DEVICES HAVING A URETHRAL CUP, AND RELATED SYSTEMS AND METHODS | October 2022 | July 2025 | Allow | 34 | 1 | 0 | Yes | No |
| 17995723 | INFUSING DISSOLVED OXYGEN INTO I.V. FLUIDS TO PROVIDE SHORT TERM EMERGENCY OXYGENATION OF VENOUS BLOOD FOR COMPROMISED OR TRAUMA PATIENTS | October 2022 | February 2026 | Allow | 40 | 1 | 1 | Yes | No |
| 17917319 | RESPONSIVE ABSORBENT ARTICLES | October 2022 | November 2025 | Allow | 37 | 2 | 0 | Yes | No |
| 17917457 | METHOD FOR PRODUCING AN IMPLANT FOR INSERTING INTO AN EYE, IN PARTICULAR FOR INSERTING INTO THE SCHLEMM'S CANAL OF AN EYE | October 2022 | December 2025 | Abandon | 38 | 0 | 1 | No | No |
| 17907125 | MULTI-LAYER URINE CAPTURE DEVICE AND RELATED METHODS | September 2022 | September 2025 | Allow | 36 | 2 | 0 | Yes | No |
| 17800792 | A COLLECTING DEVICE | August 2022 | April 2025 | Allow | 32 | 1 | 0 | No | No |
| 17795661 | MEDICAL FLUID THERAPY SYSTEM AND METHOD EMPLOYING DISTILLATION | July 2022 | March 2025 | Allow | 32 | 0 | 0 | No | No |
| 17759172 | Lymphatic Access, Drainage, And Shunting | July 2022 | May 2025 | Abandon | 34 | 1 | 0 | No | No |
| 17868092 | URINE COLLECTION SYSTEMS, AND METHODS OF MAKING AND USING THE SAME | July 2022 | March 2025 | Allow | 32 | 1 | 0 | Yes | No |
| 17793504 | MEDICAL DEVICES FOR SHUNTS, OCCLUDERS, FENESTRATIONS AND RELATED SYSTEMS AND METHODS | July 2022 | August 2025 | Allow | 37 | 1 | 1 | Yes | No |
| 17793338 | DEVICES CONTAINING CELLULAR MEMBRANE AND USES THEREOF | July 2022 | April 2025 | Allow | 33 | 1 | 0 | Yes | No |
| 17758316 | URINE COLLECTION DEVICES HAVING A RELATIVELY WIDE PORTION AND AN ELONGATED PORTION AND RELATED METHODS | July 2022 | March 2025 | Allow | 33 | 1 | 0 | Yes | No |
| 17786538 | OSTOMY SYSTEM FOR PREDICTING A SITE OF LEAKAGE | June 2022 | April 2025 | Allow | 34 | 1 | 0 | No | No |
| 17778912 | INCONTINENCE & STOMA SCENT PATCH | May 2022 | April 2025 | Allow | 35 | 1 | 0 | No | No |
| 17774190 | SYRINGE-SHAPED SPRAYING DEVICE | May 2022 | March 2025 | Allow | 35 | 1 | 0 | No | No |
| 17773200 | SYSTEMS AND METHODS FOR NEUROVASCULAR INTERVENTIONS | April 2022 | April 2025 | Allow | 36 | 1 | 0 | Yes | No |
| 17771198 | PISTON VALVING FOR SERIALLY CONNECTABLE DRUG MODULES OF A COMBINATORIAL DRUG DELIVERY DEVICE | April 2022 | October 2024 | Allow | 30 | 0 | 0 | No | No |
| 17717745 | CATHETER | April 2022 | November 2025 | Allow | 43 | 2 | 0 | No | No |
| 17714767 | ARRANGEMENT FOR MODIFYING AN INTERNAL EYE PRESSURE IN VIVO | April 2022 | August 2025 | Allow | 41 | 1 | 1 | No | No |
| 17708147 | Percutaneous Potts Shunt Devices and Related Methods | March 2022 | November 2025 | Allow | 43 | 2 | 0 | No | No |
| 17702490 | MALE EXTERNAL CATHETER | March 2022 | July 2025 | Abandon | 40 | 1 | 0 | No | No |
| 17691300 | STRETCH LAMINATE FOR INCONTINENT DEVICE | March 2022 | September 2025 | Allow | 43 | 2 | 0 | Yes | No |
| 17689160 | DIAPER SET EQUIPPED WITH EXCRETA INDUCING SEAT | March 2022 | September 2024 | Allow | 30 | 1 | 0 | No | No |
| 17688816 | BIODEGRADABLE TOBACCO-BASED ABSORBENT ARTICLE | March 2022 | July 2024 | Abandon | 29 | 1 | 0 | No | No |
| 17683943 | METHOD AND APPARATUS FOR HUMAN BRAIN NEUROPROTECTION DURING SURGERY | March 2022 | February 2026 | Allow | 47 | 1 | 1 | No | No |
| 17633596 | BAG SYSTEM FOR COLLECTING BLOOD FROM ANIMALS | February 2022 | November 2024 | Abandon | 33 | 1 | 0 | No | No |
| 17597983 | DEVICE AND METHOD FOR PREPARING A DONOR ORGAN FOR TRANSPLANTATION | January 2022 | February 2025 | Abandon | 37 | 1 | 0 | No | No |
| 17583307 | REUSABLE SANITARY NAPKIN AND A COMBINED PANTY AND REUSABLE SANITARY NAPKIN UNDERWEAR | January 2022 | August 2024 | Abandon | 31 | 1 | 0 | No | No |
| 17582041 | ABSORBENT BODY WITH TOPSHEET COMPOSITE | January 2022 | February 2025 | Allow | 37 | 3 | 0 | No | No |
| 17273371 | CONTAINER ARRANGEMENT, METHOD OF FILLING A CONTAINER ARRANGEMENT, AND USE OF A SOLUTION AS A DIALYSIS SOLUTION | January 2022 | May 2025 | Allow | 50 | 1 | 0 | No | No |
| 17558071 | COMPRESSION BODYSUIT RETRACTOR FOR BOWEL MOVEMENT | December 2021 | August 2024 | Allow | 32 | 2 | 0 | No | No |
| 17600274 | RESERVOIR ASSEMBLY FOR PROVIDING CARDIOPLEGIC SOLUTION CONTAINING BICARBONATE ION, AND METHOD FOR MANUFACTURING THE SAME | December 2021 | August 2025 | Allow | 47 | 3 | 0 | No | No |
| 17542592 | ABSORBENT CORE COMPRISING A HIGH LOFT CENTRAL LAYER AND TWO DIFFERENT SUPERABSORBENT POLYMERS | December 2021 | March 2025 | Allow | 39 | 3 | 0 | No | No |
| 17615497 | SOURCE CONTAINER CONNECTOR | November 2021 | March 2025 | Allow | 39 | 1 | 0 | No | No |
| 17607637 | DIALYSIS SYSTEMS AND METHODS | October 2021 | April 2025 | Allow | 41 | 1 | 0 | No | No |
| 17510660 | Nonwoven And Absorbent Articles Having The Same | October 2021 | August 2025 | Allow | 45 | 4 | 0 | No | No |
| 17509691 | DRUG SECURITY SYSTEMS AND METHODS | October 2021 | September 2024 | Allow | 35 | 1 | 0 | No | No |
| 17505508 | SYSTEM AND METHOD FOR A NURSING PAD | October 2021 | September 2024 | Abandon | 35 | 2 | 0 | Yes | No |
| 17503983 | PROSTHETIC DEVICES FOR A DECEASED HUMAN BODY AND METHODS OF USE THEREOF | October 2021 | September 2023 | Allow | 22 | 0 | 0 | No | No |
| 17502286 | Automatic In Vitro Diagnostic Medical Device for Intraventricular Drainage | October 2021 | March 2025 | Allow | 41 | 3 | 0 | No | No |
| 17603173 | IMPROVED OXYGENATOR FOR USE WITH EXTRACORPOREAL SUPPORT OF PREMATURE FETUS | October 2021 | December 2024 | Allow | 38 | 1 | 0 | No | No |
| 17483404 | Fluid Transfer Device and Packaging Therefor | September 2021 | May 2025 | Allow | 44 | 1 | 0 | No | No |
| 17435985 | ABSORBENT BODY, ABSORBENT ARTICLE AND METHOD FOR ADJUSTING PERMEATION SPEED | September 2021 | October 2024 | Abandon | 38 | 1 | 0 | No | No |
| 17434416 | A SENSOR PATCH FOR ATTACHMENT TO A BASE PLATE | August 2021 | November 2024 | Allow | 39 | 1 | 0 | Yes | No |
| 17434045 | EXTRACORPOREAL BLOOD LINE SET AND BLOOD TREATMENT MACHINE | August 2021 | March 2025 | Allow | 42 | 3 | 0 | No | Yes |
| 17434277 | IMPLANT COMPRISING COATING LAYER FOR OPHTHALMOPATHY | August 2021 | October 2024 | Abandon | 37 | 1 | 0 | No | No |
| 17400558 | SENSOR SYSTEM AND MEDICAL DEVICE | August 2021 | February 2025 | Allow | 42 | 2 | 0 | Yes | No |
| 17392930 | SELF-ADHESIVE ABSORBENT HYGIENIC PATCH WORN ON THE BODY | August 2021 | April 2024 | Abandon | 32 | 1 | 0 | No | No |
| 17310112 | INJECTION CANNULA, ECMO SYSTEM | July 2021 | October 2024 | Allow | 39 | 1 | 0 | No | No |
| 17423419 | METHOD AND DEVICE FOR TREATING EYE DISEASE | July 2021 | July 2025 | Allow | 48 | 2 | 0 | No | No |
| 17354388 | CEREBROSPINAL FLUID PURIFICATION SYSTEM | June 2021 | December 2024 | Allow | 42 | 2 | 0 | Yes | No |
| 17350414 | ATTACHING MEMBER | June 2021 | September 2024 | Allow | 39 | 1 | 0 | No | No |
| 17415582 | SYSTEM FOR CONTINUOUS RENAL REPLACEMENT THERAPY | June 2021 | March 2025 | Abandon | 45 | 2 | 0 | No | No |
| 17349978 | HEMODIALYSIS SYSTEM INCLUDING CONTINUOUS GLUCOSE MONITORING | June 2021 | September 2025 | Abandon | 51 | 2 | 0 | No | No |
| 17325232 | Anti-permeable, anti-side leakage diapers, pull ups and training pants, and a production line for producing the same | May 2021 | March 2024 | Abandon | 34 | 0 | 1 | No | No |
| 17293570 | THERMALLY REGULATED TRANSDERMAL DRUG DELIVERY SYSTEM | May 2021 | April 2025 | Allow | 47 | 2 | 0 | No | No |
| 17287100 | IMPLANTABLE DEVICE FOR TREATING HYPERVOLEMIA | April 2021 | October 2024 | Allow | 42 | 1 | 0 | No | No |
| 17285250 | ELASTIC DIAPER ELEMENT | April 2021 | June 2025 | Allow | 50 | 2 | 1 | No | No |
| 17283749 | EXTRACORPOREAL BLOOD TREATMENT APPARATUS AND METHOD FOR MONITORING PRESSURES IN AN EXTRACORPOREAL BLOOD TREATMENT APPARATUS | April 2021 | January 2024 | Allow | 33 | 0 | 0 | No | No |
| 17282397 | NEUROTOXIN PREFILLED VIAL | April 2021 | August 2024 | Allow | 40 | 2 | 0 | Yes | No |
| 17195707 | RECTAL INSERTION DEVICE | March 2021 | May 2024 | Abandon | 38 | 1 | 0 | No | No |
| 17178539 | OUTLET VALVE FOR AN OSTOMY APPLIANCE | February 2021 | February 2025 | Allow | 48 | 1 | 1 | No | No |
| 17178302 | APERTURED SUBSTRATE AND ABSORBENT ARTICLES COMPRISING THE SAME | February 2021 | December 2024 | Abandon | 46 | 2 | 0 | No | No |
| 17173047 | INCONTINENCE PRODUCT | February 2021 | March 2024 | Abandon | 37 | 1 | 0 | No | No |
| 17257653 | DISPOSABLE WEARABLE ARTICLE | January 2021 | June 2024 | Abandon | 41 | 1 | 0 | No | No |
| 17257217 | SYSTEM AND METHOD FOR EXTRACORPOREAL CARBON MONOXIDE REMOVAL WITH PHOTOTHERAPY | December 2020 | April 2024 | Allow | 39 | 1 | 0 | No | No |
| 17250220 | Elastic Super Absorbent Polymer Sheet | December 2020 | April 2024 | Abandon | 40 | 1 | 0 | No | No |
| 17252291 | MOISTURE ASSESSMENT SYSTEM FOR WOUND CARE | December 2020 | May 2025 | Allow | 53 | 4 | 0 | Yes | No |
| 16951312 | REUSABLE MENSTRUAL CUP FOR EASY REMOVAL WITHOUT PAIN | November 2020 | December 2023 | Allow | 37 | 0 | 0 | No | No |
| 17092995 | Blood Treatment Systems | November 2020 | December 2025 | Abandon | 60 | 2 | 1 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner KIM, ERIN ASA.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 0.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner KIM, ERIN ASA works in Art Unit 3781 and has examined 44 patent applications in our dataset. With an allowance rate of 65.9%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 41 months.
Examiner KIM, ERIN ASA's allowance rate of 65.9% places them in the 27% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.
On average, applications examined by KIM, ERIN ASA receive 1.64 office actions before reaching final disposition. This places the examiner in the 32% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.
The median time to disposition (half-life) for applications examined by KIM, ERIN ASA is 41 months. This places the examiner in the 22% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +23.6% benefit to allowance rate for applications examined by KIM, ERIN ASA. This interview benefit is in the 70% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.
When applicants file an RCE with this examiner, 40.0% of applications are subsequently allowed. This success rate is in the 91% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.
This examiner enters after-final amendments leading to allowance in 30.0% of cases where such amendments are filed. This entry rate is in the 43% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.
When applicants request a pre-appeal conference (PAC) with this examiner, 200.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 99% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.
This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 99% percentile among all examiners. Of these withdrawals, 100.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.
When applicants file petitions regarding this examiner's actions, 200.0% are granted (fully or in part). This grant rate is in the 100% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 46% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 49% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.